Evidence map›Paper›PMID 42368399›Full record

ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2026

Laboratory diagnosis of pertussis: A survey on provincial public health laboratory methods.

Courtney Meilleur, Jennifer Grant, Gregory Tyrrell, Jessica Minion, Paul Van Caeseele, Julianne Kus, Brigitte Lefebvre, Todd Hatchette, Guillaume Desnoyers, Lei Jiao and 2 more

Abstract read
In one paragraph

Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Courtney MeilleurVaccine Preventable Bacterial Diseases, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.
Jennifer GrantBritish Columbia Centre for Disease Control, Vancouver, BC.
Gregory TyrrellProvincial Laboratory for Public Health, Edmonton, AB.
Jessica MinionRoy Romanow Provincial Laboratory, Regina, SK.
Paul Van CaeseeleCadham Provincial Laboratory, Winnipeg, MB.
Julianne KusPublic Health Ontario Laboratory, Toronto, ON.
Brigitte LefebvreLaboratoire de santé publique du Québec, Institut nationale de santé publique du Québec, Sainte-Anne-de- Bellevue, QC.
Todd HatchettePathology and Laboratory Medicine Program, Nova Scotia Health Authority, Halifax, NS.
Guillaume DesnoyersNew Brunswick Public Health Laboratory, Dr. Georges-L.-Dumont University Hospital Centre, Moncton, NB.
Lei JiaoNewfoundland and Labrador Public Health Laboratory, St. John's, NL.
Heidi PaulinProvincial Laboratory Services, Health Prince Edward Island, Charlottetown, PE.
Raymond TsangVaccine Preventable Bacterial Diseases, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pertussis, a vaccine preventable respiratory illness caused by the bacterium Objective: To examine the breadth and depth of pertussis strain surveillance currently being carried out across Canada. Methods: A survey was sent to all ten provincial public health laboratories inquiring how pertussis was diagnosed or identified in the laboratory, including the polymerase chain reaction (PCR) diagnostic methods, bacteriological culture, identification and strain characterization such as molecular typing and antibiotic susceptibility testing. Results: Nine of the ten provincial laboratories provided responses. Five provincial laboratories reported performing bacteriological culture, and some only from specimens that tested positive by PCR. Long-term storage of submitted and historical specimens took place in six laboratories. Identification of Conclusion: Given the global increase in pertussis, with the emergence of macrolide-resistant and pertactin-deficient strains, strain characterization should be added to the Canadian national pertussis surveillance program.

Indexed as

diagnostic proceduresnational surveillance programpertussisrecommendationsstrain characterization

Identifiers

PMID42368399
PMCPMC13308499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.